Table 3.

MS development odds ratios according to high levels of serum VEGFb in basal study.

	IDF criteria		ATP-III criteria
	OR (95%CI)	p value	OR (95%CI)	p value
Model 1a
High_VEGFb vs Low VEGFb	0.65 (0.43–1.006)	0.053	0.45 (0.27–0.75)	0.002
Model 2b
High_VEGFb vs Low VEGFb	0.61 (0.39–0.96)	0.035	0.38 (0.23–0.65)	<0,001
Model 3c
High_VEGFb vs Low VEGFb	0.65 (0.41–1.02)	0.066	0.41 (0.24–0.70)	0.001
Model 4d
High_VEGFb vs Low VEGFb	0.79 (0.47–1.31)	0.4	0.51 (0.29–0.93)	0.03

^aOdds ratios calculated by logistic regression adjusted by sex, age and IMC.

^bOdds ratios calculated by logistic regression adjusted by sex, age, waist circumference, systolic blood pressure, diastolic blood pressure, serum triglycerides, fasting glucose and HDL- cholesterol levels.

^cOdds ratios calculated by logistic regression adjusted by the same variables than model 2 plus serum hs-CRP and physical activity (IPAQ categories).

^dOdds ratios calculated by logistic regression adjusted by the same variables than model 3 plus an interaction term between VEGFb levels and physical activity (IPAQ categories).